Journal ArticleOPEN ACCESS

Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales

Open Forum Infectious Diseases (2024) 11(7)
DOI: 10.1093/ofid/ofae377
5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Clinical and Laboratory Standards Institute stated that cefpodoxime susceptibility among Enterobacterales can be inferred from cefazolin, but this may overcall cefpodoxime resistance. We report a categorical agreement rate of 64% for cefazolin and 97% for ceftriaxone with cefpodoxime (P = .0001). Ceftriaxone appears to be a more useful cefpodoxime surrogate.

Author supplied keywords

Cite

CITATION STYLE

APA

Lambert, K. V., Demkowicz, R., Murray, A., Howard, C., & Slain, D. (2024). Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales. Open Forum Infectious Diseases, 11(7). https://doi.org/10.1093/ofid/ofae377

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free